Neurodegenerative Diseases: Biology & Therapeutics
December 2 - 5, 2020
Abstract Deadline: September 18, 2020
Aaron Gitler, Stanford University
Richard Ransohoff, Third Rock Ventures
Scott Small, Columbia University
Li-Huei Tsai, Massachusetts Institute of Technology
You are cordially invited to participate in the eleventh meeting on Neurodegenerative Diseases to be held at Cold Spring Harbor Laboratory. The meeting will begin with dinner and the first session on the evening of Wednesday, December 2, and will conclude with lunch on Saturday, December 5, 2020.
A primary goal of the meeting is to provide a forum where medical scientists from academia can interact with scientists from the biopharmaceutical industry, thus forging a community of academic and industry researchers who recognize that they have much to learn from each other. Rational drug discovery for neurodegenerative diseases has begun to yield compounds and treatments that are now entering clinical settings. For human studies utilizing these compounds and treatments to be maximally informative, it is crucial that scientists from academia and industry meet regularly to exchange data and ideas.
This meeting will consist of six to seven oral sessions plus one poster session. The aim is to populate half of each oral session with speakers from academia and the other half from industry; speakers will be invited as well as selected from submitted abstracts.
Propagation of Neurodegenerative Disease
Network Mechanisms of Neurodegenerative Disease
Neuroinflammation & Glial Biology of Neurodegeneration
ApoE and Lipid Metabolism
RNA Metabolism in Neurodegenerative Disease
The Endolysosome, Autophagy and Other Targets in Therapeutics
Confirmed Session Chairs:
Joachim Herz, UT Southwestern
Henne Holstege, Vrije Universiteit Amsterdam, Netherlands
Sally John, Biogen
Alfred Sandrock, Biogen
Anne Schaefer, Icahn School of Medicine at Mount Sinai
Robert Brown, University of Massachusetts Medical School
Olav Michael Andersen, Aarhus University, Denmark
Frank Bennett, Ionis Pharmaceuticals
Gonçalo Castelo-Branco, Karolinska Institutet, Sweden
Michael Heneka, German Center for Neurodegenerative Diseases (DZNE)
David Holtzman, Washington University School of Medicine
Yadong Huang, University of California, San Francisco
Martin Kampmann, University of California, San Francisco
Jennifer Lippincott-Schwartz, HHMI Janelia Farm Research Campus
Leonard Petrucelli, Mayo Clinic
Virginia Lee, University of Pennsylvania Perelman School of Medicine
Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentations will be made by the organizers and individual session chairs. The status of abstracts (i.e., talk or poster) will be posted as soon as decisions have been made by the organizers. Please bring this announcement to the attention of any of your colleagues who may be interested in participating in the meeting.
All questions pertaining to registration, fees, housing, meals, transportation, visas, abstract submission or any other matters should be directed to Catie Carr at firstname.lastname@example.org.
Cold Spring Harbor Laboratory is eager to have as many young people as possible attend this meeting. As such, we have some funds set aside to partially support students and postdocs. Please register and apply in writing to Catie Carr at email@example.com stating your eligibility and need for financial support. Preference will be given to those submitting abstracts.
We look forward to seeing you at Cold Spring Harbor Laboratory at the beginning of December 2020.
Partial support for this meeting provided by:
Academic Package: $1,255
Graduate/PhD Student Package: $1,050
Corporate Package: $1,610
Academic/Student No-Housing Package: $860
Corporate No-Housing Package: $1,085
Regular packages are all-inclusive and cover registration, food, housing, parking, a wine-and-cheese party, cocktail reception, and lobster banquet. No-Housing packages include all costs except housing. Full payment is due four weeks prior to the meeting.